Mechanistic pathways linking gut microbial metabolites, microbial structural products, and host-microbe co-metabolites to mitochondrial function.
Gut-derived metabolites affect mitochondrial function, but current evidence is mostly preclinical and should guide future research rather than immediate clinical practice.
Where it sits
this study against the rest of the mots-c corpusSummary and findings
This systematic review synthesizes evidence linking gut-derived microbial metabolites to mitochondrial function. It evaluates ten classes of metabolites for their effects on mitochondrial endpoints. The review identifies butyrate, propionate, indoxyl sulfate, and lipopolysaccharide as having moderate certainty in their effects on mitochondrial function.
Abstract
Gut-derived microbial metabolites modulate host mitochondrial function. To our knowledge, no prior systematic review has synthesized evidence linking these metabolites to direct mitochondrial endpoints across all major metabolite classes. PubMed, Scopus, and Web of Science were systematically searched through March 2026 for studies examining direct mitochondrial endpoints in relation to ten classes of gut-derived metabolites. Gut-derived microbial metabolites exert diverse effects on mitochondrial function, ranging from bioenergetic enhancement to direct toxicity. After contextual evidence was excluded from the certainty assessment, four metabolite-mitochondrial outcome groupings had moderate certainty: butyrate, propionate, indoxyl sulfate, and lipopolysaccharide. Evidence for p-cresyl sulfate, H₂S, and urolithin A was rated low; evidence for the remaining metabolite classes was low or very low. Butyrate generally enhances mitochondrial biogenesis, ATP generation, and electron transport chain activity across multiple experimental models. Indoxyl sulfate generally impaired mitochondrial function, whereas p-cresyl sulfate produced concentration- and model-dependent effects. PGC-1α emerges as a central regulatory node, integrating microbial metabolic signals to control mitochondrial biogenesis and oxidative metabolism. Many microbial metabolites demonstrate concentration-dependent biphasic effects. These findings support a mechanistic microbiome-mitochondrial framework in which diverse gut-derived molecules converge on a limited set of mitochondrial control nodes: electron transport chain activity, reactive oxygen species handling, biogenesis, and mitophagy. The evidence base is predominantly preclinical; these insights should be considered hypothesis-generating.
Background
This paper addresses the relationship between gut-derived microbial metabolites and mitochondrial function, a topic of growing interest due to the role of mitochondria in energy metabolism and cellular health. Previous studies have shown that these metabolites can influence mitochondrial activity, but a comprehensive synthesis of evidence across different metabolite classes was lacking. This study aims to fill that gap by systematically reviewing the literature on this topic.
Methods
The authors conducted a systematic review of studies from PubMed, Scopus, and Web of Science up to March 2026. The review focused on ten classes of gut-derived microbial metabolites and their direct effects on mitochondrial endpoints. The certainty of evidence was assessed, excluding contextual evidence, to focus on direct mitochondrial outcomes.
Results
The review found that butyrate generally enhances mitochondrial biogenesis, ATP generation, and electron transport chain activity. Indoxyl sulfate was found to impair mitochondrial function, while p-cresyl sulfate showed concentration- and model-dependent effects. The review highlighted PGC-1α as a key regulatory node in mitochondrial biogenesis and oxidative metabolism. Overall, the evidence was rated as moderate for some metabolites and low or very low for others.
Interpretation
The findings suggest that gut-derived microbial metabolites can have significant effects on mitochondrial function, but the evidence is largely preclinical and should be viewed as hypothesis-generating. While some metabolites like butyrate show consistent positive effects, others like indoxyl sulfate are detrimental. The concentration-dependent nature of these effects and the reliance on preclinical models limit the immediate clinical relevance. Future research should aim to confirm these findings in clinical settings.
Key findings
- Butyrate enhances mitochondrial biogenesis and ATP generation.
- Indoxyl sulfate impairs mitochondrial function.
- p-Cresyl sulfate effects are concentration- and model-dependent.
- PGC-1α is a central regulatory node for mitochondrial biogenesis.
- Evidence is predominantly preclinical and hypothesis-generating.
Limitations
- Predominantly preclinical evidence
- Concentration-dependent effects
- Model-specific findings
- Hypothesis-generating nature
- Low or very low certainty for many metabolites